Mereo Biopharma Group PLC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NASDAQ
Mereo BioPharma Group plc has issued its proxy statement for the 2026 Annual General Meeting, detailing proposals for shareholder votes including the adoption of annual accounts, auditor re-appointment, and director re-elections.
NASDAQ
Mereo BioPharma Group plc will hold its Annual General Meeting on May 13, 2025, to vote on key resolutions including the adoption of the annual report, auditor re-appointment, director re-elections, and executive compensation.
NASDAQ
Mereo BioPharma Group plc will hold its Annual General Meeting on May 23, 2024, to vote on key resolutions including the adoption of the annual report, auditor re-appointment, and director re-elections.